“Financial Reset” Is Coming in 2023

I became an eye surgeon.

January 03, 2023 View in Browser / Unsubscribe Editor's Note: The message below from one of our partners is one we believe you should take a close look at. This System Has Failed You... Now It Can PAY You More than twenty years ago, I left a lucrative career on Wall Street to study medicine. I became an eye surgeon. But I soon learned that American medicine is just as rotten and corrupt as American finance. So I left medicine too – and started a third career, writing about stocks... and helping ordinary folks learn how to retire wealthy and worry-free. Believe me, I know how badly these systems have failed you. How much aggravation they've probably caused. But if you've ever wanted to stick it to either one of them – you urgently need to see this. It's a huge development I've waited 40 years for... Creating the biggest moneymaking opportunity I've ever seen in my life. And it's happening while everyone is distracted by the crashing market. I'm telling you – as a physician, medical researcher, MBA, and market analyst for decades – it's time to pay attention to this one inflation- and recession-resistant sector. Health and medicine are undergoing a radical transformation. Trillions are changing hands. And the COVID-19 crisis put this transformation on steroids. The research firm Forrester reported that health care "accelerated by a decade in a matter of months." And the CEO of Johnson & Johnson just went on record predicting that "the next 10 years will bring greater medical innovation than the last 100 years combined." When you've seen this... I guarantee you'll never look at the health care system... your own health decisions... or your investing dollars.... the same way ever again. This information could lead you to a series of triple-digit gains... maybe even save your life or the life of someone you love. That's why I'm sharing the most important research of my life, completely for free, at this private link. Here's to our health, wealth, and a great retirement, Dr. David Eifrig, MD, MBA Senior Partner, Stansberry Research       This email was sent to indra21poetra@gmail.com because you made a great decision to receive our newsletter.   Trading involves risk. The information provided is NOT trading advice. Neither the Editors, the Publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the newsletter. Past performance is no guarantee of future performance. This recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability for any purchase or order made from any company or entity mentioned or recommended in this email. The information provided is for educational purposes only. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Actual results may differ. Nothing here constitutes a recommendation respecting the particular security illustrated. Copyright © 2021 Leinster 134, London, SW35GB This ad is send on behalf of Stansberry Research, 1125 N Charles ST, Baltimore, MD 21201. If you would like to unsubscribe from receiving offers from Stansberry click here. This offer is brought to you by Web Impact LLC. Al Jerozolimskie 85, 02-001 Warsaw, Poland. If you would like to unsubscribe from receiving offers brought to you by Web Impact LLC click link below. All Rights Reserved. Unsubscribe